Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge
Information source: Steward St. Elizabeth's Medical Center of Boston, Inc.
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Sinus Disease
Intervention: Bacitracin (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: Steward St. Elizabeth's Medical Center of Boston, Inc. Official(s) and/or principal investigator(s):
Peter Catalano, MD, Principal Investigator, Affiliation: Steward St. Elizabeth's Medical Center of Boston, Inc.
Summary
This study will evaluate the efficacy of a nasopore sponge dressing soaked in Bacitracin VS
a sponge soaked in Saline / and the administration of oral antibiotics.
Clinical Details
Official title: Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge After Functional Endoscopic Sinus Surgery
Study design: Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Primary outcome: Efficacy
Detailed description:
Same as above
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patient having primary or revision sinus surgery. Aged 18 years or older. Patients
must have middle meatus easily identified. The type of surgery will not be influenced
by the participation in this study.
Exclusion Criteria:
- Age less then 18
- Known sensitivity to Bacitracin
- Pregnancy
Locations and Contacts
St. Elizabeth's Medical Center, Brighton, Massachusetts 02135, United States
Additional Information
Starting date: July 2010
Last updated: January 2, 2014
|
